
Sign up to save your podcasts
Or


Based on Podcast App listening data
Comprehensive Insights into Bioidentical Hormone Replacement Therapy with Dr. Erika Schwartz, author of “The New Hormone Solution.” In this episode of the Intelligent Medicine Podcast, Dr. Ronald Hoffman speaks with Dr. Erika Schwartz, an expert in bioidentical hormone replacement therapy. They discuss the evolution and controversies surrounding hormone therapies, including the impact of the Women's Health Initiative study. Dr. Schwartz shares her insights on the importance of a tailored approach to hormone replacement, the benefits of different forms of estrogen and progesterone, and the role of testosterone, DHEA, and lifestyle choices in comprehensive care for menopause and andropause. Additionally, they explore the topics of women's sexuality, the pros and cons of osteoporosis drugs, and the necessity of incorporating a holistic lifestyle approach for overall health and longevity.
Dr. Hoffman continues his conversation with Dr. Erika Schwartz, author of “The New Hormone Solution.”
Dr. Garth Nicolson, Founder, President, Chief Scientific Officer, and Emeritus Research Professor of Molecular Pathology at the Institute for Molecular Medicine in Huntington Beach, California, and Research Advisor for Nutritional Therapeutics, explains how membrane damage from free radicals and loss of mitochondrial transmembrane potential contribute to declining energy with age, noting studies in older adults showing improved energy output, fatigue, cognition, mood, and activity after NTFactor lipids, a protected phospholipid supplement balanced toward mitochondrial lipid composition. He describes evidence of lipid delivery using fluorescent-tagged lipids in sperm, with improved motility, and discusses applications including wound healing in veterans, removal of hydrophobic toxins via a concentration-driven “conveyor belt” process, and improved transport of nutrients like CoQ10. He details articles on normal aging, menopause-related changes supported by membranes, dementia risk linked to hearing loss, and rat studies showing delayed hearing loss with NTFactor, and mentions research on EMF sensitivity and planned schizophrenia trials.
Dr. Hoffman continues his conversation with Dr. Garth Nicolson, Founder, President, Chief Scientific Officer, and Emeritus Research Professor of Molecular Pathology at the Institute for Molecular Medicine in Huntington Beach, California, and Research Advisor for Nutritional Therapeutics.
The “Enhanced Games”, with no-holds-barred performance-enhancing drugs, yields scant advantages over “clean” contests; Does saturated fat increase insulin resistance? Can a heart attack victim avoid statin use with CoQ10? Omega-3 fish oil shows promise vs. type 2 diabetes; Motorized e-scooter use needs to be regulated NOW!
AI founders call for Congress to set guardrails against AI-accelerated bioweapon development; Deprescribing thyroid medication in seniors; Low-arginine/high lysine diets vs. herpes; Researchers test the “5 second rule” for dropped food; Long-term antidepressant use comes under new scrutiny.
Nutritionist Leyla Muedin discusses research showing simple strength tests—grip strength and a five-rep sit-to-stand chair test—predict longevity in older women. In a University at Buffalo study of over 5,000 women ages 63–99 followed for eight years, stronger grip and faster chair-stand times were linked to lower mortality; every additional 7 kg of grip strength corresponded to a 12% reduction in death risk, and faster chair-stands were also associated with improved survival, even after adjusting for activity, cardiovascular fitness, and inflammation. She emphasizes prioritizing muscle-strengthening alongside aerobic exercise and suggests accessible resistance options (weights, bodyweight moves, or household items) with professional guidance as needed. She then cites UK Biobank data linking long-term statin use to declines in grip strength and appendicular lean mass, urging discussion with physicians and added vigilance, especially for those also using GLP-1 drugs that may reduce protein intake and muscle mass.
From the publisher's feed
Ranked by our users in the last 21 days

772 Listeners

1,859 Listeners

7,188 Listeners

1,526 Listeners

1,999 Listeners

4,870 Listeners

3,420 Listeners

9,146 Listeners

1,797 Listeners

334 Listeners

132 Listeners

1,772 Listeners

833 Listeners

289 Listeners

1,223 Listeners